CHASE LODGE HOSPITAL PHARMACY LTDActive

Company number 08786628Private limited companyIncorporated 2013

Key figures

£978,666+11.7%
Net assets 2024/25
-4.9%
Average annual change 2020/21–2024/25
0500 k1 m1.5 m2020/212021/222022/232023/242024/25

Like most small UK companies, CHASE LODGE HOSPITAL PHARMACY LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02 m4 m6 m2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand308,0572,8442,7894,90211,561
Total assets3,188,3273,270,0324,058,6044,938,4714,538,778
Total liabilities—2,275,7473,192,2154,074,8153,572,754
Net assets / total equity1,198,0671,009,730882,368875,838978,666
Average number of employees77777

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: CHASE LODGE HOSPITAL PHARMACY LTD

Company

CHASE LODGE HOSPITAL PHARMACY LTD is a private limited company registered with Companies House under company number 08786628. It was incorporated on 22 Nov 2013. Its status is active. The registered office is in London (NW7). Its nature of business (SIC 2007) is hospital activities (86101).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were £978,666, up 11.7% on the previous year. Cash at bank and in hand was £11,561. Total assets were £4,538,778 and total liabilities £3,572,754. The company had an average of 7 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered. 1 of 2 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Dec 2026. The next confirmation statement is due by 4 Apr 2027.